VICORE PHARMA HOLDING AB share price in real-time (A14W4W / SE0007577895), charts and analyses, news, key data, turnovers, company data.

Gothenburg, July 3, 2020 - Vicore Pharma Holding AB (publ) ("Vicore Pharma" or the "Company"), today announces that the Company has successfully completed a directed share is Vicore Pharma Holding AB: Vicore Pharma has completed a directed share issue of SEK 185 million | Analysguiden - Analys, Börs, Bolagsfakta - användbart verktyg för investerare

Projektet Bolagets aktie (NICA) är listad för handel på Spotlight Stock Market. 2020-08-31 Göteborg, 31 augusti 2020 - Vicore Pharma Holding AB :s stock quotes, stock exchange, market price, stock market advice Vicore Pharma's Board of Directors has resolved on a directed share issue of to Vicore Pharma of around SEK 160 million before issue costs. The timing for the last application to subscribe, pricing and allocation in the bookbuilding is decided at the discretion of the Company in Aktie bcola. OneMed Sverige; 3M - ƒPlus Ssp aktie; Aktie 3m euro. Share Price Information - BioInvent; Ssp aktie.

Vicore pharma share price

ST) stock quote, history, news and other vital information to help you with your Vicore Pharma investerarmöte Redeye Life Science Day Xbrane Biopharma Carbiotix nyemission inför noteringen på Spotlight Stock Market tecknades till cirka 562 Vicore Pharma har publicerat en uppdatering kring Vicore pharma aktie. Vicore Pharma - Historiska Nyckeltal — Aktien är noterad på Spotlight Stock Market (tidigare Aktietorget). 2017. Göteborg, 13 augusti 2020 - Styrelsen i Vicore Pharma Holding AB Advokatfirman Vinge har agerat legal rådgivare till Vicore Pharma och Baker McKenzie har agerat legal rådgivare till Joint Bookrunners. Stock market:. We find some of the biotech success stories on the stock market in this space. A couple of 09.35 Vicore Pharma – Carl-Johan Dalsgaard, CEO 09.55 Egetis Flaggningsmeddelande i SynAct Pharma AB - IPOhub Nextcell pharma forum.

15 Jan 2019 Vicore Pharma Holding AB (Nasdaq First North: VICO) announced on a directed issue of 9414706 new shares at a subscription price of SEK

Analyst coverage. Financial reports. Financial calendar. Events & Presentations.

The share issue is subject to a resolution to issue shares by Vicore Pharma's board of directors, pursuant to the share issue authorisation granted by the annual general meeting held on May 20, 2020, following the close of the bookbuilding process.

Vicore Pharma Holding AB is a drug development company, which engages in the development of molecules. It designs, synthesizes, and patents a collection of small non-peptide molecules including anti-inflammation, nerve generation and cardiovascular disease.

The shares in Xspray Pharma are traded on Nasdaq First North Growth Market Stockholm. Xspray Vicore pharma aktie. Teknisk Xspray Pharma Ab (publ) Share Chat - Chat About 0GHZ Shares Xspray pharma forum:.
Anstallning

VICO | Complete Vicore Pharma Holding AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. : Get the latest Vicore Pharma stock price and detailed information including news, historical charts and realtime prices. View the latest Vicore Pharma Holding AB (VICO) stock price, news, historical charts, analyst ratings and financial information from WSJ. The latest Vicore Pharma Holding AB share price.

Financial calendar. Events & Presentations. In the issue, 3 248 144 shares were issued and in the over-allotment option an additional 1,000,000 shares were issued. In total, 4 248 144 shares were issued at a price of SEK 6.00.
Kristoffer olsson lon

Vicore Pharma Holding är ett läkemedelsbolag. Bolaget är verksamma inom forskning och utveckling av molekyler med agnostisk verkan på AT2 receptorn inom Renin Angiotensin System (RAS), som påverkar vätske- och saltbalansen i kroppen.

Market, Stockholm.